Urticarial Vasculitis After First Denosumab Injection in an Osteoporotic Woman Diagnosed with Cushing’s Syndrome
Denosumab is a human-derived monoclonal immunoglobulin G2 antibody against the receptor activator of nuclear factor kappa B ligand, inhibiting the differentiation and function of osteoclast precursor cells by its antiosteoclastic action. Denosumab is approved for postmenopausal, glucocorti coid-indu...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Society of Endocrinology and Metabolism of Turkey
2022-09-01
|
| Серии: | Endocrinology Research and Practice |
| Предметы: | |
| Online-ссылка: | https://endocrinolrespract.org/index.php/pub/article/view/1123 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|